VASCULAR BIOGENICS LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34221
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12155
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 1159
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
C07K PEPTIDES 6130
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
A23J PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS 119

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0015,183 METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTSJul 06, 17Jan 18, 18[A61K, C12N, A61N]
2017/0258,818 Oxidized Lipids and Treatment or Prevention of FibrosisMay 23, 17Sep 14, 17[A61K]
2016/0143,968 TREATMENT METHODS USING ADENOVIRUSNov 23, 15May 26, 16[A61K, C12N]
2015/0320,773 TREATMENT OF INFLAMMATIONDec 11, 12Nov 12, 15[A61K]
2013/0209,450 Compositions and Methods for Treating Glioblastoma GBMJan 05, 11Aug 15, 13[A61K, A61N]
2013/0052,165 Methods of Producing Adenovirus Vectors and Viral Preparations Generated TherebyJan 12, 11Feb 28, 13[A61K, C12N, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9771385 Oxidized lipidsNov 25, 15Sep 26, 17[C07F]
9682154 Methods of inducing responsiveness to anti-angiogenic agentFeb 04, 14Jun 20, 17[A61K, C07K]
9566288 High-purity phospholipidsFeb 25, 15Feb 14, 17[A61K, C07F]
9567605 Methods for use of a specific anti-angiogenic adenoviral agentJan 05, 11Feb 14, 17[A61K, C07H, A01N, C12N, C07K]
9403887 Endothelial cell-specific polynucleotides and use thereofSep 24, 14Aug 02, 16[C07H, A61K, C12N, C07K]
9254297 Formulations and dosage forms of oxidized phospholipidsMar 11, 13Feb 09, 16[A61K, C07F]
9206206 Oxidized lipid compounds and uses thereofNov 05, 09Dec 08, 15[A61K, C07F, C07C]
9200056 FAS-chimera adenovirus vectorOct 29, 14Dec 01, 15[A61K, A01N, C12N, C07K]
9006217 High-purity phospholipidsMar 15, 13Apr 14, 15[A61K, C07F]
8999960 Oxidized thiophospholipid compounds and uses thereofOct 01, 09Apr 07, 15[A61K, C07F, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2018/0015,184 METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTSAbandonedJul 12, 16Jan 18, 18[A61K]
2017/0007,718 METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTSAbandonedSep 04, 15Jan 12, 17[A61K, C12N]
2014/0155,467 PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESISAbandonedOct 21, 13Jun 05, 14[C12N]
2013/0295,053 Methods of Producing Adenovirus Vectors and Viral Preparations Generated TherebyAbandonedMar 14, 13Nov 07, 13[C12N]
2013/0280,216 Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentAbandonedMar 12, 13Oct 24, 13[A61K, C12N]
2013/0280,217 Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentAbandonedMar 12, 13Oct 24, 13[A61K, C12N]
2013/0225,525 Combined Treatment Utilizing VB-201AbandonedMar 14, 13Aug 29, 13[A61K]
2013/0203,707 Oxidized Lipid Compounds and Uses ThereofAbandonedMar 14, 13Aug 08, 13[C07F, C07C]
2013/0172,294 Treatment with VB-201AbandonedJan 05, 11Jul 04, 13[A61K]
2012/0329,758 Combined Treatment Utilizing VB-201AbandonedJan 05, 11Dec 27, 12[A61K, C07F, A61P]
2012/0252,883 Method and Composition to Increase Radiation-Induced Tumor Therapeutic EffectsAbandonedDec 07, 10Oct 04, 12[A61K, C12N, A61P]
2012/0130,108 PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDSAbandonedJan 26, 12May 24, 12[C07F, C07C]
2011/0319,479 POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIAAbandonedJun 20, 11Dec 29, 11[A61K, A61P]
2011/0230,450 PLATELET-ACTIVATING FACTOR (PAF) ANALOGS AND USES THEREOFAbandonedOct 05, 08Sep 22, 11[A61K, A61P]
2011/0207,985 PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESISAbandonedMay 02, 11Aug 25, 11[A61N]
2011/0201,677 PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAMEAbandonedApr 27, 11Aug 18, 11[A61K, C07H, C12N, A61P]
2010/0298,226 POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIAAbandonedJul 31, 07Nov 25, 10[A61K, C07H, C12N, A61P, C07K]
2010/0282,634 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of AngiogenesisAbandonedFeb 22, 07Nov 11, 10[C12N, B65D]
2010/0081,193 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisAbandonedNov 13, 09Apr 01, 10[C07H]
2009/0068,207 Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular DiseaseAbandonedApr 11, 06Mar 12, 09[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.